In this proposed systematic review and meta-analysis, we will explore the impacts of vitamin D supplementation on markers of inflammation, including tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in patients with T2D. This evidence concerns the gene CRP and type 2 diabetes mellitus.